China is said to give access to it locally-produced coronavirus vaccines to the world?
According to a a WHO official on Tuesday;
China to have its locally-produced Covid-19 vaccines, assessed by the World Health Organisation (WHO), as a step towards making them available for international use.
Hundreds of thousands of essential workers and other groups considered at high risk in China have been given locally-developed vaccines.
Even as clinical trials, had not been fully completed, which is raising safety concerns among experts.
Socorro Escalate, WHO’s coordinator for essential medicines and health technologies in the Western Pacific region, told a news conference conducted online that;
China had held preliminary discussions with WHO to have its vaccines included in a list for emergency use.
Incomplete China ‘s Vaccine to be available?
Since the proper or ‘completed’ vaccine isn’t available for coronavirus (covid-19), some temporary incomplete vaccines are being used for treatments.
Socorro Escalate of WHO said;
“Potentially through this emergency use listing the quality and safety of these vaccines and efficacy could be assessed and then this could be made available for our licensees,”
China has at least four experimental vaccines in the final stage of clinical trials.
Among them two are developed by state-backed China National Biotec Group (CNBG).
The remaining two are from Sinovac Biotech and CanSino Biologics respectively.
They are tested in such countries as Pakistan, Indonesia, Brazil, Russia and the United Arab Emirates.
Last month, the UAE authorised the emergency use of a CNBG vaccine, the first international emergency clearance for one of China’s vaccines, just six weeks after human trials began in the Gulf Arab state.
When will the final vaccine be available!
WHO Director-General Tedros Adhanom Ghebreyesus, addressing the end of a two-day meeting of its Executive Board on the pandemic, said:
“We will need vaccines and there is hope that by the end of this year we may have a vaccine. There is hope.”
Nine experimental vaccines are in the pipeline of the WHO-led COVAX global vaccine facility that aims to distribute 2 billion doses by the end of 2021.